Literature DB >> 23296905

Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.

Dilek Alpsar1, Ali Agacfidan, Nadine Lübke, Jens Verheyen, Haluk Eraksoy, Atahan Cağatay, Emel Bozkaya, Rolf Kaiser, Baki Akgül.   

Abstract

In Turkey, the first HIV/AIDS case was reported in 1985. Since then the number of persons with HIV infection has increased, HIV is getting a public health problem. The aim of this study was to determine HIV-1 subtype diversity, drug resistance and gag cleavage site mutations among 20 HIV-infected men having sex with men from Istanbul, Turkey. The most prevalent subtype was found to be subtype B (50 %), but also the non-B subtypes A1, C and CRF02_AG, CRF03_AB and CRF06_cpx were found. Resistance-associated mutations were found in 6 patients (30 %) with 2/6 patients being therapy-experienced and 4/6 therapy-naïve at the time-point of analysis. In these patients, the nucleoside reverse transcriptase inhibitor (NRTI)-associated resistance mutations M41L, T215C, V75I, T69N, the non-NRTI associated mutations V106I, E138A, K103N and the protease inhibitor associated mutations Q58E and V82I were detected. Two virus strains also presented Gag cleavage site mutations. With increasing numbers of HIV-infected Turkish patients that require anti-retroviral treatment, HIV-1 drug-resistance testing is strongly recommended in order to choose the most active drug combination for therapy to achieve better clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296905     DOI: 10.1007/s00430-012-0285-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  26 in total

1.  Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.

Authors:  Michela Violin; Alessandro Cozzi-Lepri; Rossella Velleca; Antonella Vincenti; Salvatore D'Elia; Francesco Chiodo; Florio Ghinelli; Ada Bertoli; Antonella d'Arminio Monforte; Carlo Federico Perno; Mauro Moroni; Claudia Balotta
Journal:  AIDS       Date:  2004-01-23       Impact factor: 4.177

2.  An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs.

Authors:  Noortje M van Maarseveen; Dorien de Jong; Charles A B Boucher; Monique Nijhuis
Journal:  J Acquir Immune Defic Syndr       Date:  2006-06       Impact factor: 3.731

Review 3.  HIV‑1 molecular epidemiology in the Balkans: a melting pot for high genetic diversity.

Authors:  Maja Stanojevic; Ivailo Alexiev; Danail Beshkov; Deniz Gökengin; Maria Mezei; Janos Minarovits; Dan Otelea; Simona Paraschiv; Mario Poljak; Snjezana Zidovec-Lepej; Dimitrios Paraskevis
Journal:  AIDS Rev       Date:  2012 Jan-Mar       Impact factor: 2.500

4.  Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy.

Authors:  L T Bacheler; E D Anton; P Kudish; D Baker; J Bunville; K Krakowski; L Bolling; M Aujay; X V Wang; D Ellis; M F Becker; A L Lasut; H J George; D R Spalding; G Hollis; K Abremski
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany.

Authors:  Eugen Schülter; Mark Oette; Melanie Balduin; Stefan Reuter; Jürgen Rockstroh; Gerd Fätkenheuer; Stefan Esser; Thomas Lengauer; Ali Agacfidan; Herbert Pfister; Rolf Kaiser; Baki Akgül
Journal:  Med Microbiol Immunol       Date:  2011-04-02       Impact factor: 3.402

6.  Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.

Authors:  Jens Verheyen; Elena Litau; Tobias Sing; Martin Däumer; Melanie Balduin; Mark Oette; Gerd Fätkenheuer; Jürgen K Rockstroh; Ulrike Schuldenzucker; Daniel Hoffmann; Herbert Pfister; Rolf Kaiser
Journal:  Antivir Ther       Date:  2006

7.  Prevalence and pattern of drug resistance mutations among antiretroviral-treated HIV-1 patients with suboptimal virological response in Malaysia.

Authors:  Kok Keng Tee; Adeeba Kamarulzaman; Kee Peng Ng
Journal:  Med Microbiol Immunol       Date:  2006-01-11       Impact factor: 3.402

8.  Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.

Authors:  Mark Oette; Rolf Kaiser; Martin Däumer; Ruth Petch; Gerd Fätkenheuer; Horst Carls; Jürgen Kurt Rockstroh; Dirk Schmalöer; Jürgen Stechel; Torsten Feldt; Herbert Pfister; Dieter Häussinger
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-15       Impact factor: 3.731

9.  Primary drug-resistance in HIV-positive patients on initiation of first-line antiretroviral therapy in Germany.

Authors:  Mark Oette; R Kaiser; M Däumer; D Akbari; G Fätkenheuer; J K Rockstroh; J Stechel; A Rieke; S Mauss; D Schmalöer; K Göbels; C Vogt; M Wettstein; D Häussinger
Journal:  Eur J Med Res       Date:  2004-05-28       Impact factor: 2.175

10.  Antiviral activities of 9-R-2-phosphonomethoxypropyl adenine (PMPA) and bis(isopropyloxymethylcarbonyl)PMPA against various drug-resistant human immunodeficiency virus strains.

Authors:  R V Srinivas; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more
  4 in total

1.  HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey.

Authors:  Muammer Osman Köksal; Hayati Beka; Nadine Lübke; Jens Verheyen; Haluk Eraksoy; Atahan Cagatay; Rolf Kaiser; Baki Akgül; Ali Agacfidan
Journal:  Med Microbiol Immunol       Date:  2015-04-28       Impact factor: 3.402

Review 2.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

3.  Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD).

Authors:  Claudia Reinheimer; Anna Wesner; Oliver T Keppler; Hans Wilhelm Doerr; Eva Herrmann; Martin Stürmer; Christoph Stephan
Journal:  Med Microbiol Immunol       Date:  2016-01-08       Impact factor: 3.402

4.  Molecular epidemiology of HIV-1 strains in Antalya, Turkey.

Authors:  Dilara Inan; Murat Sayan
Journal:  J Int AIDS Soc       Date:  2014-11-02       Impact factor: 5.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.